Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diprobase Cream is a topical emollient and moisturiser used to treat and protect red, inflamed, damaged, dry, or chapped skin. It is commonly indicated for conditions such as eczema, atopic dermatitis, psoriasis, ichthyosis (extremely dry skin), and general dry or irritated skin. The cream works by forming a protective barrier on the skin surface that helps retain moisture and prevent further irritation from external factors. Its mechanism of action is physical rather than pharmacological; it hydrates the stratum corneum (outermost layer of the skin) by occlusion and reducing transepidermal water loss. Diprobase Cream does not contain steroids or other pharmacologically active ingredients but relies on its emollient properties to soothe symptoms[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diprobase cream.